This year’s Healthcare Innovation Award gives special attention to innovations which focus on the hardest-to-reach children
GSK and Save the Children have launched their fourth annual USD 1 million Healthcare Innovation Award, which rewards innovations in healthcare that help to reduce child deaths in developing countries and have the potential to reach even more children.
In Ethiopia in 2013, approximately 6 in 100 children died before their fifth birthday and, in 2015, there were nearly 90,000 neonatal deaths. This year, until 7 September, organizations from across the country can nominate innovative healthcare approaches they have implemented. These innovations must have resulted in tangible improvements to under-5 child survival, be sustainable and have the scope to be scaled-up and replicated.
The Award is one of a number of initiatives from GSK and Save the Children’s five-year partnership, which combines the two organizations’ expertise and skills with the aim to help save one million children’s lives. Since 2013, more than a dozen inventive approaches – from a breast milk pasteurization device to an affordable diarrhea treatment kit – have been recognized through the Award. This year, as well as recognizing approaches that have helped reduce child deaths, the Award will give special attention to innovations that focus on the hardest-to-reach children.
A judging panel, made up of experts from the fields of public health, science and academia, will award all or part of the funds to one or more of the best healthcare innovations. Further details on the judging process and criteria can be found online at www.healthcareinnovationaward.org.